Work

Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies

Year: 2023

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2023.04.003

Authors: Dilan A. Patel, Fei Wan, Kathryn Trinkaus, Daniel G. Guy, Natasha Edwin, Marcus Watkins, Nancy L. Bartlett, Amanda Cashen, Todd A. Fehniger, Armin Ghobadi, Neha-Mehta Shah, Brad S. Kahl

Institution: Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Cancer Center Support Grant, G921763661

OpenAlex ID: W4366824813

FWCI: 0.165

Cites: 29

Cited by: 1

Related to: 10